Ligand validation:3I26

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3I26 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3I26_NAG_D_5157	27%	55%	0.225	0.875	0.5	1.2	-	1	0	0	100%	1
3I26_NAG_B_5156	14%	64%	0.247	0.802	0.42	0.96	-	-	0	0	100%	1
3I26_NAG_A_5157	12%	62%	0.334	0.865	0.47	0.97	-	-	0	0	100%	1
3I26_NAG_A_5180	2%	54%	0.398	0.639	0.57	1.18	-	1	0	0	100%	1
3I27_NAG_D_5156	40%	46%	0.167	0.876	0.44	1.61	-	3	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_G_505	100%	86%	0.023	0.994	0.21	0.5	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.